TG Therapeutics, Inc.

NasdaqCM:TGTX Stock Report

Market Cap: US$4.7b

TG Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:TGTX Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
11 Nov 24SellUS$754,875Laurence CharneyIndividual25,000US$30.20
11 Nov 24SellUS$152,200Sagar LonialIndividual5,000US$30.44
05 Nov 24SellUS$489,600Yann EchelardIndividual20,000US$24.48
20 Jun 24SellUS$432,889Sagar LonialIndividual25,933US$16.87
13 Mar 24SellUS$79,675Sagar LonialIndividual5,000US$15.94
12 Mar 24SellUS$351,340Laurence CharneyIndividual22,000US$15.97
05 Jan 24SellUS$333,025Laurence CharneyIndividual17,500US$19.03
03 Jan 24SellUS$809,431Sean PowerIndividual47,867US$16.91

Insider Trading Volume

Insider Buying: TGTX insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of TGTX?
Owner TypeNumber of SharesOwnership Percentage
State or Government46,6550.0325%
Individual Insiders9,920,0846.91%
General Public26,162,14518.2%
Institutions107,390,45274.8%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 65.26% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
15.3%
BlackRock, Inc.
21,956,197US$714.2m92.8%0.01%
10.7%
The Vanguard Group, Inc.
15,387,290US$500.5m12.4%0.01%
6.34%
State Street Global Advisors, Inc.
9,094,158US$295.8m35.8%0.01%
5.71%
Michael Weiss
8,200,919US$266.8m0%no data
3.4%
Opus Point Partners
4,874,010US$158.6m0%100.0%
2.5%
Pictet Asset Management Limited
3,582,583US$116.5m10.5%0.1%
2.23%
Geode Capital Management, LLC
3,205,228US$104.3m-0.04%0.01%
1.79%
Woodline Partners LP
2,565,322US$83.4m80.7%0.73%
1.77%
Soleus Capital Management, L.P.
2,534,540US$82.4m-30.5%6.4%
1.59%
Opaleye Management Inc.
2,280,000US$74.2m0%12.68%
1.41%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
2,020,808US$65.7m20.2%0.02%
1.25%
Morgan Stanley, Investment Banking and Brokerage Investments
1,798,924US$58.5m31.1%0.01%
1.2%
Deep Track Capital, LP
1,725,000US$56.1m-39.9%1.75%
1.16%
Bank of America Corporation, Asset Management Arm
1,660,998US$54.0m-19.6%0.02%
1.14%
Hood River Capital Management LLC
1,630,349US$53.0m3.65%0.81%
0.98%
Northern Trust Global Investments
1,412,144US$45.9m10.6%0.01%
0.91%
Goldman Sachs Group, Investment Banking and Securities Investments
1,311,266US$42.7m38.7%0.02%
0.87%
Goldman Sachs Asset Management, L.P.
1,245,161US$40.5m9.29%0.01%
0.83%
Charles Schwab Investment Management, Inc.
1,184,609US$38.5m0.67%0.01%
0.82%
FMR LLC
1,183,885US$38.5m-2.59%no data
0.79%
683 Capital Management, LLC
1,135,000US$36.9m-18.9%3.81%
0.74%
Two Sigma Investments, LP
1,062,860US$34.6m-21.9%0.08%
0.67%
UBS Asset Management AG
959,882US$31.2m14%no data
0.58%
Susquehanna International Group, LLP, Asset Management Arm
830,692US$27.0m-36.9%0.04%
0.57%
BNY Asset Management
824,590US$26.8m67.4%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 05:57
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

TG Therapeutics, Inc. is covered by 21 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Jason WittesAegis Capital Corporation
Alec StranahanBofA Global Research
Jonathan AschoffBrean Capital